Soterix Medical announces new clinical trial for their tDCS system

Soterix Medical Inc. has recently been awarded a contract by the National Institute of Drug Abuse (NIDA) and National Institutes of Health (NIH) for a Phase I clinical trial of their portable self-administered tDCS device for the treatment of cocaine addiction. The Icahn School of Medicine at Mount Sinai (ISMMS) has partnered with Soterix Medical as the clinical center overseeing the feasibility trial at the outpatient rehabilitation center Samaritan Village.

Soterix Medical is an industry leading company that develops professional clinical and lab grade tDCS devices. For more information on the new clinical trial, visit prnewswire.

For more information about Soterix Medical, visit

Share the Post:

Related Posts